<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01102647</url>
  </required_header>
  <id_info>
    <org_study_id>B2009:133</org_study_id>
    <nct_id>NCT01102647</nct_id>
  </id_info>
  <brief_title>Cholesterol Metabolism in Heterozygous Phytosterolemia</brief_title>
  <official_title>Assessment of Cholesterol Metabolism in Heterozygous Phytosterolemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine the effect of plant sterols on cholesterol absorption
      and synthesis in people with heterozygous phytosterolemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A plant sterol supplementation study will be conducted in individuals who are heterozygous
      for phytosterolemia compared to non-carriers. The study will use a double-blind, randomised,
      crossover, placebo-controlled design in which participants will consume 2 treatments
      including 1.6 g of plant sterol pills and a placebo pill, each for 4 weeks. A 4 week washout
      period will separate the two treatment periods. Plant sterol concentrations will be measured
      by gas liquid chromatography and absorption will be measured by the ratio of campesterol to
      lathosterol in plasma. Cholesterol absorption and synthesis will be measured by dual stable
      isotope technique, involving simultaneous administration of 13C-cholesterol and deuterium
      oxide, respectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in plasma LDL-cholesterol</measure>
    <time_frame>29 days</time_frame>
    <description>Other studies have found 10% reduction in plasma LDL-cholesterol after 2.2-3.2 gram of plant sterol supplementation for 4 weeks in heterozygous phytosterolemia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase plasma plant sterols</measure>
    <time_frame>29 days</time_frame>
    <description>We will use a control group and compare the level of increase in plasma plant sterol levels in both group over the course of plant sterol consumption</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Phytosterol ester</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant sterol compared with placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>phytosterol ester</intervention_name>
    <description>1.6 g phytosterols/day for 29 days</description>
    <arm_group_label>Phytosterol ester</arm_group_label>
    <other_name>Phytocell Phytosterols, NPN#: 80012048</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  heterozygous for phytosterolemia, wild-type.

        Exclusion Criteria:

          -  Pregnant,

          -  Previous heart attack,

          -  Kidney disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter J Jones, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2010</study_first_submitted>
  <study_first_submitted_qc>April 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2010</study_first_posted>
  <last_update_submitted>April 28, 2011</last_update_submitted>
  <last_update_submitted_qc>April 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Peter J Jones</name_title>
    <organization>University of Manitoba</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

